XML 16 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Cash flows from operating activities    
Net income (loss) $ 13,939,816 $ (2,712,785)
Adjustments to reconcile net income (loss) to cash used in operating activities:    
Depreciation and amortization 45,966 29,762
Stock-based compensation expense 1,124,242 294,677
Accretion of notes payable discount 91,428
Gain on disposition of assets (850)
Loss (gain) from equity method investment (267,740) 7,000
Changes in assets and liabilities:    
Accounts and other receivable (5,218,494) (42,065)
Prepaid and other assets (2,527,983) (183,446)
Inventory (10,030,838) 9,920
Deffered revenue 1,044,225
Accounts payable and accrued expenses 1,542,347 (191,332)
Net cash used in operating activities (348,459) (2,697,691)
Cash flows from investing activities    
Purchase of property and equipment (205,290) (52,775)
Investment in joint venture (714,500) (247,000)
Net cash used in investing activities (919,790) (299,775)
Cash flows from financing activities    
Proceeds from sale of common stock 19,470,005 5,496,002
Proceeds from sale of preferred stock 1,000,000
Proceeds from exercise of options and warrants 913,465
Payment of offering costs (1,457,922) (592,764)
Net cash provided by financing activities 18,925,548 5,903,238
Net increase in cash and cash equivalents 17,657,299 2,905,772
Cash and cash equivalents at beginning of period 893,138 950,237
Cash and cash equivalents at end of period 18,550,437 3,856,009
Supplemental disclosure of cash flow information    
Interest paid 15,000
Income taxes paid
Supplemental disclosure of non-cash investing and financing transactions    
Inventory moved to property, plant and equipment $ 117,220